Novartis buying US biotech firm
Novartis is buying Anthos Therapeutics from Blackstone’s drug development division, as it makes a bet on an experimental drug aimed at preventing strokes in patients with an irregular heart rhythm.
Novartis buying US biotech company
Novartis is buying Anthos Therapeutics from Blackstone’s drug development division, as it makes a bet on an experimental drug aimed at preventing strokes in patients with an irregular heart rhythm.
Men Can Get Breast Cancer, Too—but We Don’t Talk About It Enough
Breast cancer cases in men only account for 1% of all breast cancer diagnoses. But, knowing the signs, causes, and treatments remain important.